Bartronics India Ltd Share Price – NSE  / BSE

IT - Software, Small Cap

Avio Smart Market Stack (ASMS), formerly known as Bartronics India, has initiated an expanded collaboration with Huwel Lifesciences to introduce a range of patented molecular diagnostic products across multiple healthcare segments in India.

The development follows the recently signed Shareholders' Agreement between the two companies, under which they aim to jointly scale advanced diagnostic technologies and bring them to institutional and healthcare markets across the country.

Huwel Lifesciences has developed multiple patented diagnostic technologies and is building a strong pipeline of new products, with several additional patents and platforms currently under development. The company's capabilities span RT-PCR diagnostic kits, point-of-care molecular testing devices, and disease detection panels. Research, assay development, and manufacturing are carried out within Huwel's own facilities.

Positioning itself as a fully indigenous diagnostics innovator, Huwel is among the few molecular diagnostics companies in India with the capability to design, develop, and manufacture most components of its diagnostic platforms in-house, aligning with the Government of India's ?Make in India? initiative.

Powered by Capital Market - Live News

Avio Smart Market Stack (ASMS) (formerly known as Bartronics India) has signed a Share Subscription cum Shareholders' Agreement with Hyderabad-based Huwel Lifesciences pursuant to and in furtherance of the MoU signed between the parties in September 2025.

Under the agreement, Avio Smart Market Stack will acquire a minority stake in Huwel and collaborate on business development and project execution. Under this structure, ASMS is contractually entitled to receive a defined share of the net project revenues arising from orders secured and executed through its institutional engagement and business development efforts.

Huwel Lifesciences' tuberculosis diagnostic platform has recently undergone a Health Technology Assessment (HTA) conducted by the Department of Health Research under the Ministry of Health & Family Welfare, Government of India. The assessment evaluated molecular tuberculosis diagnostic platforms deployed nationwide. As per its findings, Huwel's Quantiplus? MTB FAST platform enables testing at an approximate cost of Rs 340 per sample, whereas molecular testing systems currently used in government programmes typically range between Rs 700 and Rs 1,000 per test. A key differentiator for the Quantiplus platform is its compatibility with open RT-PCR systems. This enables the Government to leverage the thousands of RT-PCR machines installed across India during the COVID-19 response, facilitating rapid deployment of the platform without the need for proprietary hardware or significant additional capital expenditure.

Powered by Capital Market - Live News

Bartronics India announced the appointment of Dr. Raja Krishna Murthy M as Head - Agri Tech Business, strengthening its leadership as the company scales its agri-tech and climate-led growth initiatives.

The appointment aligns with Bartronics' strategic focus on Project Avio Agritech, its integrated agri-tech platform designed to create new, scalable revenue streams across agricommerce, sustainable agriculture, digital advisory, and high-integrity carbon and climate solutions, while leveraging the company's extensive rural reach.

Powered by Capital Market - Live News

Net profit of Bartronics India reported to Rs 2.45 crore in the quarter ended December 2025 as against net loss of Rs 0.33 crore during the previous quarter ended December 2024. Sales rose 454.99% to Rs 48.34 crore in the quarter ended December 2025 as against Rs 8.71 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News